Robert-Bosch-Krankenhaus

Robert-Bosch-Krankenhaus (RBK) is a leading German medical center and research hospital located in Stuttgart, founded by Robert Bosch in 1940. It operates as a charitable institution under the Robert Bosch Stiftung and is renowned for its integration of high-end patient care with cutting-edge clinical research. The hospital is particularly distinguished by the Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology (IKP), which is a global leader in pharmacogenomics and personalized medicine. As a designated Comprehensive Cancer Center, RBK focuses on oncology, cardiology, and nephrology, hosting numerous Phase 1 through Phase 3 clinical trials. The institution maintains strong academic partnerships, notably with the University of Tübingen, to translate laboratory findings into clinical practice. Its commitment to innovation is reflected in its specialized centers for tumor diseases and genomic medicine.